Stroke
Researchers from National Institute of Neurological Disorders & Stroke publish findings in stroke
Published in Drug Law Weekly, January 26th, 2010
According to recent research from the United States, "We investigated the regulatory effects of GRK2 on D2 dopamine receptor signaling and found that this kinase inhibits both receptor expression and functional signaling in a phosphorylation-independent manner, apparently through different mechanisms. Overexpression of GRK2 was found to suppress receptor expression at the cell surface and enhance agonist-induced internalization, whereas short interfering RNA knockdown of endogenous GRK2 led to an increase in cell surface receptor expression and decreased agonist-mediated endocytosis."
"These effects were not due to GRK2-mediated phosphorylation of the D2 receptor as a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2010-01-26)
More Articles from Drug Law Weekly
- A.P. Pharma, Inc.
A.P. Pharma Receives $2.5 Million Milestone Payment - Adeptra
Adeptra Survey Reveals Banks and Card Issuers Are Investing in Technology to Speed-up and Improve Reporting and Prevention of Fraud - Aerospace Industries Association
Mandell Named Head of Membership and Business Development - Age and Aging
Dr. Zein Obagi, Preeminent Inventor of Skin Care Products, Challenges Anti-Competitive Practices of Obagi Medical Products - ARCA biopharma, Inc.
ARCA biopharma Receives Notice of Allowance for Patent for Treating Heart Failure Patients with Bucindolol Based on Genetic Testing - BioNJ
BioNJ to Kick Off 2010 with 17th Annual Meeting to Support New Jersey's Biotech Innovation - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
